NCT07500714Recruiting
Integrating Digital Phenotypes and AI-Driven Cognitive-Behavioral Therapy: Advancing Precision Medicine in Depression Through Digital Medicine
Source: ClinicalTrials.gov · Last updated 30 Mar 2026
Brief summary (registry, in English)
This project aims to integrate digital phenotyping and AI-driven iCBT into a comprehensive platform for MDD diagnosis and treatment in Taiwan. The study will explore dynamic, real-time behavioral and physiological markers to refine diagnostic classifications and optimize personalized therapeutic strategies.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 20 Mar 2026
- Start date
- 1 Jun 2025
- Primary completion date
- Jun 2027
- Lead sponsor
- National Science and Technology Council, Taiwan
- Diseases
- Depression
- NCT number
- NCT07500714
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 1 Jun 2025 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Psychotic disorders, bipolar affective disorder, a substance use disorders in the past 6 months, active suicidal or homicidal ideation (per assessment or HAMD\>3)
- Unstable or active medical illness.
Other
- Scores of 5 ( Markedly ill), 6,(Severely ill), and 7 (Among the most extremely ill) according to the Clinical Global Impression Scale-Severity (CGI-S)
Who the study is looking for
- (1) Aged 18-75 years
- Diagnosis of major depressive disorder disorder (Based on Diagnostic Statistical Manual 5)
- 21-item Hamilton Depression Scale (HAMD21)\>17
- No changes in current psychiatric treatment for depression (e.g., no treatment, antidepressant medication, psychotherapy, or non-invasive brain stimulation) within the past four weeks, and
- Full competency to understand the study details and provide written informed consent
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mind-Body Interface Research Center (MBI Lab & Care) Coordinator of this site? Confirm its status | Taichung | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.